Dominant rhabdomyolysis linked to a recurrent ATP2A2 variant reducing SERCA2 function in muscle
Brain · 2025
DOI: 10.1093/brain/awaf067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2025. Verfasst von Sivasankar Malaichamy und 32 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, Canada. Hauptthemen laut MEDLINE: Sarcoplasmic Reticulum Calcium-Transporting ATPases, Rhabdomyolysis, Muscle, Skeletal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Canadian Institutes of Health Research (CIHR), Precision Health for Neuromuscular Diseases, Transnational Team.
Abstract (Originalsprache)
Rhabdomyolysis is an acute failure of cellular homeostasis resulting in muscle breakdown, triggered by trauma, infection, drugs or strenuous exercise. Recurrent rhabdomyolysis is often associated with genetic and metabolic defects of skeletal muscle. The sarcoendoplasmic reticulum Ca2+-ATPase 2 (SERCA2), encoded by the ATP2A2 gene, is an intracellular pump located in the sarcoplasmic and endoplasmic reticulum that is essential for maintaining intracellular calcium (Ca2+) homeostasis and is highly expressed in slow-twitch muscle. Heterozygous loss-of-function variants in ATP2A2 have previously been associated with dominant skin diseases, but not with rhabdomyolysis. In this study, we report a rare novel heterozygous missense variant in the ATP2A2 gene (c.1583G>A, p.R528Q) identified in 14 affected individuals from three unrelated families with recurrent rhabdomyolysis. Muscle biopsy revealed mild myopathic changes with fibre type uniformity, core-like structures and Z-band streaming, but normal levels of SERCA2 protein. Ca2+ imaging showed that sarcoplasmic reticulum Ca2+ reuptake mediated by SERCA was significantly slower in myotubes derived from patient fibroblasts carrying the c.1583G > A variant. We hypothesize that the ATP2A2 variant impairs SERCA2a function in slow-twitch muscle, disrupting SR Ca2+ reuptake and causing cytosolic Ca2+ overload following a trigger, leading to recurrent rhabdomyolysis. Morphant zebrafish embryos with atp2a2a knockdown showed morphological and functional muscle abnormalities, with a reduction in body length and trunk muscle area associated with a reduction in locomotor activity in zebrafish larvae. Co-injection of wild-type human SERCA2a mRNA, but not variant SERCA2a mRNA, resulted in complete rescue of the phenotype. This study reveals a novel association between a heterozygous ATP2A2 variant and autosomal dominant recurrent rhabdomyolysis. Both in vitro and in vivo studies provide evidence that the variant alters SERCA2 function, causing abnormal intracellular Ca2+ homeostasis in skeletal muscle, resulting in rhabdomyolysis. The work not only increases understanding of autosomal dominant rhabdomyolysis but also provides a diagnostic conclusion for three generations of affected individuals across the three families.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, Canada.
- Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
- Department of Pediatrics, University Hospital Center Zagreb, Zagreb 10000, Croatia.
- Department of Neuropediatrics, Developmental Neurology and Social Pediatrics, Centre for Neuromuscular Disorders in Children, University Hospital Essen, University of Duisburg-Essen, Essen 45147, Germany.
- Institute of Neuropathology, Justus Liebig University Giessen, Giessen 35392, Germany.
- Department of Pathology, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands.
ORCID-Profile: Sivasankar Malaichamy, Romane Idoux, Kiran Polavarapu, Katarina Šikić, Rachel Thompson, Sally Spendiff, Anne Schänzer, Andreas Hentschel, Vera Dobelmann, Meyke Schouten, Tobias Ruck, Ulrike Schara-Schmidt, Erik-Jan Kamsteeg, Danijela Petković Ramadža, Antonia Jakovčević, Tamara Žigman, Mislav Čavka, Veronika Karcagi, Steven Laurie, Leslie Matalonga, Sergi Beltran, Rita Horvath, Nicol Voermans, Andreas Roos, Ivo Barić, Hanns Lochmüller
Förderung
- Canadian Institutes of Health Research (CIHR)
- Precision Health for Neuromuscular Diseases
- Transnational Team
- Network Grant
- Canada Foundation for Innovation
- Canada Research Chairs program
- Canada Research Chair in Neuromuscular Genomics and Health
- European Commission
Zitieren
APA
Malaichamy, S., Idoux, R., Polavarapu, K., Šikić, K., Holla, E., Thompson, R., Spendiff, S., Schänzer, A., Küsters, B., Freeman, E., Hentschel, A., O'Neil, D., Carmona-Martinez, R., Dobelmann, V., Tucht, C., Schouten, M., Ruck, T., Schara-Schmidt, U., Kamsteeg, E. J., …, & Lochmüller, H. (2025). Dominant rhabdomyolysis linked to a recurrent ATP2A2 variant reducing SERCA2 function in muscle. Brain. https://doi.org/10.1093/brain/awaf067
Vancouver
Malaichamy S, Idoux R, Polavarapu K, Šikić K, Holla E, Thompson R, et al. Dominant rhabdomyolysis linked to a recurrent ATP2A2 variant reducing SERCA2 function in muscle. Brain. 2025. doi:10.1093/brain/awaf067
BibTeX
@article{Malaichamy2025,
author = {Malaichamy, Sivasankar and Idoux, Romane and Polavarapu, Kiran and Šikić, Katarina and Holla, Elisa and Thompson, Rachel and Spendiff, Sally and Schänzer, Anne and Küsters, Benno and Freeman, Emily and Hentschel, Andreas and O'Neil, Daniel and Carmona-Martinez, Ricardo and Dobelmann, Vera and Tucht, Calvin and Schouten, Meyke and Ruck, Tobias and Schara-Schmidt, Ulrike and Kamsteeg, Erik-Jan and Ramadža, Danijela Petković and Jakovčević, Antonia and Žigman, Tamara and Čavka, Mislav and Karcagi, Veronika and Herczegfalvi, Agnes and Laurie, Steven and Matalonga, Leslie and Beltran, Sergi and Horvath, Rita and Voermans, Nicol and Roos, Andreas and Barić, Ivo and Lochmüller, Hanns},
title = {Dominant rhabdomyolysis linked to a recurrent ATP2A2 variant reducing SERCA2 function in muscle},
journal = {Brain},
year = {2025},
doi = {10.1093/brain/awaf067}
}
EUVIMED